Cargando…

Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial

BACKGROUND: Protein energy wasting is associated with negative outcome in patients under chronic haemodialysis (HD). Branched‐chain amino acids (BCAAs) may increase the muscle mass. This post hoc analysis of a controlled double‐blind randomized crossover study assessed the impact of BCAAs on nutriti...

Descripción completa

Detalles Bibliográficos
Autores principales: Genton, Laurence, Teta, Daniel, Pruijm, Menno, Stoermann, Catherine, Marangon, Nicola, Mareschal, Julie, Bassi, Isabelle, Wurzner‐Ghajarzadeh, Arelene, Lazarevic, Vladimir, Cynober, Luc, Cani, Patrice D., Herrmann, François R., Schrenzel, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718019/
https://www.ncbi.nlm.nih.gov/pubmed/34519439
http://dx.doi.org/10.1002/jcsm.12780
_version_ 1784624631862263808
author Genton, Laurence
Teta, Daniel
Pruijm, Menno
Stoermann, Catherine
Marangon, Nicola
Mareschal, Julie
Bassi, Isabelle
Wurzner‐Ghajarzadeh, Arelene
Lazarevic, Vladimir
Cynober, Luc
Cani, Patrice D.
Herrmann, François R.
Schrenzel, Jacques
author_facet Genton, Laurence
Teta, Daniel
Pruijm, Menno
Stoermann, Catherine
Marangon, Nicola
Mareschal, Julie
Bassi, Isabelle
Wurzner‐Ghajarzadeh, Arelene
Lazarevic, Vladimir
Cynober, Luc
Cani, Patrice D.
Herrmann, François R.
Schrenzel, Jacques
author_sort Genton, Laurence
collection PubMed
description BACKGROUND: Protein energy wasting is associated with negative outcome in patients under chronic haemodialysis (HD). Branched‐chain amino acids (BCAAs) may increase the muscle mass. This post hoc analysis of a controlled double‐blind randomized crossover study assessed the impact of BCAAs on nutritional status, physical function, and quality of life. METHODS: We included 36 chronic HD patient features of protein energy wasting as plasma albumin <38 g/L, and dietary intakes <30 kcal/kg/day and <1 g protein/kg/day. Patients received either oral BCAA (2 × 7 g/day) or glycine (2 × 7 g/day) for 4 months (Period 1), followed by a washout period of 1 month, and then received the opposite supplement (Period 2). The outcomes were lean body mass measured by dual‐energy X‐ray absorptiometry, fat‐free mass index measured by bioelectrical impedance, resting energy expenditure, dietary intake and appetite rating, physical activity and function, quality of life, and blood parameters. Analyses were performed by multiple mixed linear regressions including type of supplementation, months, period, sex, and age as fixed effects and subjects as random intercepts. RESULTS: Twenty‐seven patients (61.2 ± 13.7 years, 41% women) were compliant to the supplementations (consumption >80% of packs) and completed the study. BCAA did not affect lean body mass index and body weight, but significantly decreased fat‐free mass index, as compared with glycine (coeff −0.27, 95% confidence interval −0.43 to −0.10, P = 0.002, respectively). BCAA and glycine intake had no effect on the other clinical parameters, blood chemistry tests, or plasma amino acids. CONCLUSIONS: Branched‐chain amino acid did not improve lean body mass as compared with glycine. Unexpectedly, glycine improved fat‐free mass index in HD patients, as compared with BCAA. Whether long‐term supplementation with glycine improves the clinical outcome remains to be demonstrated.
format Online
Article
Text
id pubmed-8718019
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87180192022-01-06 Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial Genton, Laurence Teta, Daniel Pruijm, Menno Stoermann, Catherine Marangon, Nicola Mareschal, Julie Bassi, Isabelle Wurzner‐Ghajarzadeh, Arelene Lazarevic, Vladimir Cynober, Luc Cani, Patrice D. Herrmann, François R. Schrenzel, Jacques J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: Protein energy wasting is associated with negative outcome in patients under chronic haemodialysis (HD). Branched‐chain amino acids (BCAAs) may increase the muscle mass. This post hoc analysis of a controlled double‐blind randomized crossover study assessed the impact of BCAAs on nutritional status, physical function, and quality of life. METHODS: We included 36 chronic HD patient features of protein energy wasting as plasma albumin <38 g/L, and dietary intakes <30 kcal/kg/day and <1 g protein/kg/day. Patients received either oral BCAA (2 × 7 g/day) or glycine (2 × 7 g/day) for 4 months (Period 1), followed by a washout period of 1 month, and then received the opposite supplement (Period 2). The outcomes were lean body mass measured by dual‐energy X‐ray absorptiometry, fat‐free mass index measured by bioelectrical impedance, resting energy expenditure, dietary intake and appetite rating, physical activity and function, quality of life, and blood parameters. Analyses were performed by multiple mixed linear regressions including type of supplementation, months, period, sex, and age as fixed effects and subjects as random intercepts. RESULTS: Twenty‐seven patients (61.2 ± 13.7 years, 41% women) were compliant to the supplementations (consumption >80% of packs) and completed the study. BCAA did not affect lean body mass index and body weight, but significantly decreased fat‐free mass index, as compared with glycine (coeff −0.27, 95% confidence interval −0.43 to −0.10, P = 0.002, respectively). BCAA and glycine intake had no effect on the other clinical parameters, blood chemistry tests, or plasma amino acids. CONCLUSIONS: Branched‐chain amino acid did not improve lean body mass as compared with glycine. Unexpectedly, glycine improved fat‐free mass index in HD patients, as compared with BCAA. Whether long‐term supplementation with glycine improves the clinical outcome remains to be demonstrated. John Wiley and Sons Inc. 2021-09-14 2021-12 /pmc/articles/PMC8718019/ /pubmed/34519439 http://dx.doi.org/10.1002/jcsm.12780 Text en © 2021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Genton, Laurence
Teta, Daniel
Pruijm, Menno
Stoermann, Catherine
Marangon, Nicola
Mareschal, Julie
Bassi, Isabelle
Wurzner‐Ghajarzadeh, Arelene
Lazarevic, Vladimir
Cynober, Luc
Cani, Patrice D.
Herrmann, François R.
Schrenzel, Jacques
Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial
title Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial
title_full Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial
title_fullStr Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial
title_full_unstemmed Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial
title_short Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial
title_sort glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718019/
https://www.ncbi.nlm.nih.gov/pubmed/34519439
http://dx.doi.org/10.1002/jcsm.12780
work_keys_str_mv AT gentonlaurence glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial
AT tetadaniel glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial
AT pruijmmenno glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial
AT stoermanncatherine glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial
AT marangonnicola glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial
AT mareschaljulie glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial
AT bassiisabelle glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial
AT wurznerghajarzadeharelene glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial
AT lazarevicvladimir glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial
AT cynoberluc glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial
AT canipatriced glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial
AT herrmannfrancoisr glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial
AT schrenzeljacques glycineincreasesfatfreemassinmalnourishedhaemodialysispatientsarandomizeddoubleblindcrossovertrial